PCR-RFLP assay as an option for primary HPV test

Detalhes bibliográficos
Autor(a) principal: Golfetto, Lisléia
Data de Publicação: 2018
Outros Autores: Alves, Eduardo Venâncio, Martins, Toni Ricardo, Sincero, Thais Cristine Marques, Castro, J.B.S., Dannebrock, Christian, Oliveira, Jaquelline Germano de, Levi, Jose Eduardo, Onofre, Alexandre Sherlley Casimiro, Bazzo, Maria Luiza
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/28878
Resumo: Universidade Federal de Santa Catarina. Laboratório de Biologia Molecular, Microbiologia e Sorologia. Florianópolis, SC, Brasil
id CRUZ_b5466f50d28e6ebbd09bca45e36a9158
oai_identifier_str oai:www.arca.fiocruz.br:icict/28878
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Golfetto, LisléiaAlves, Eduardo VenâncioMartins, Toni RicardoSincero, Thais Cristine MarquesCastro, J.B.S.Dannebrock, ChristianOliveira, Jaquelline Germano deLevi, Jose EduardoOnofre, Alexandre Sherlley CasimiroBazzo, Maria Luiza2018-09-19T11:56:47Z2018-09-19T11:56:47Z2018GOLFETTO, Lisléia et al. PCR-RFLP assay as an option for primary HPV test. Braz J Med Biol Res, v. 51, n. 5, e7098, 2018.0100-879Xhttps://www.arca.fiocruz.br/handle/icict/2887810.1590/1414-431x20177098engAssociação Brasileira de Divulgação Científicacancer cervicalHPVTriagemPCR-RFLPMicroarranjo PapilloCheck®Cervical cancerHPVScreeningPCR-RFLPPapilloCheck® microarrayPCR-RFLP assay as an option for primary HPV testinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Santa Catarina. Laboratório de Biologia Molecular, Microbiologia e Sorologia. Florianópolis, SC, BrasilUniversidade Federal de Santa Catarina. Laboratório de Biologia Molecular, Microbiologia e Sorologia. Florianópolis, SC, BrasilUniversidade de São Paulo. Instituto de Medicina Tropical. Laboratório de Virologia. São Paulo, SP, BrasilUniversidade Federal de Santa Catarina. Departamento de Análises Clínicas. Florianópolis, SC, BrasilPrefeitura de São Miguel do Oeste. Secretaria de Saúde. Posto Central. São Miguel do Oeste, SC, BrasilLaboratório Prevent Citopatologia. São Miguel do Oeste, SC, BrasilFundação Oswaldo Cruz. Instituto René Rachou. Grupo de Pesquisa em Imunologia Celular e Molecular. Belo Horizonte, MG, BrasilUniversidade de São Paulo. Instituto de Medicina Tropical. Laboratório de Virologia. São Paulo, SP, BrasilUniversidade Federal de Santa Catarina. Departamento de Análises Clínicas. Florianópolis, SC, BrasilUniversidade Federal de Santa Catarina. Laboratório de Biologia Molecular, Microbiologia e Sorologia. Florianópolis, SC, Brasil/Universidade Federal de Santa Catarina. Departamento de Análises Clínicas. Florianópolis, SC, BrasilPersistent human papillomavirus (HPV) infection is an essential factor of cervical cancer. This study evaluated the analytical performance of restriction fragment length polymorphism polymerase chain reaction (PCR-RFLP) assay compared to PapilloCheck® microarray to identify human papilloma virus (HPV) in cervical cells. Three hundred and twenty-five women were analyzed. One sample was used for conventional cytology and another sample was collected using BD SurePath™ kit for HPV tests. Eighty samples (24.6%) were positive for HPV gene by PCR-Multiplex and were then submitted to PCR-RFLP and PapilloCheck® microarray. There was a genotyping agreement in 71.25% (57/80) on at least one HPV type between PCR-RFLP and PapilloCheck® microarray. In 22 samples (27.5%), the results were discordant and those samples were additionally analyzed by DNA sequencing. HPV 16 was the most prevalent HPV type found in both methods, followed by HPVs 53, 68, 18, 39, and 66 using PCR-RFLP analysis, and HPVs 39, 53, 68, 56, 31, and 66 using PapilloCheck® microarray. In the present study, a perfect agreement using Cohen's kappa (κ) was found in HPV 33 and 58 (κ=1), very good for HPV 51, and good for types 16, 18, 53, 59, 66, 68, 70, and 73. PCR-RFLP analysis identified only 25% (20/80) HPV coinfection, and PapilloCheck® microarray found 62.5% (50/80). Our Cohen's kappa results indicate that our in-house HPV genotyping testing (PCR-RFLP analysis) could be applied as a primary HPV test screening, especially in low income countries. If multiple HPV types are found in this primary test, a more descriptive test, such as PapilloCheck® microarray, could be performed.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83082https://www.arca.fiocruz.br/bitstream/icict/28878/1/license.txt9193a7c197bc67acd023525e72a03240MD51ORIGINALPCR-RFLP assay.pdfPCR-RFLP assay.pdfapplication/pdf192291https://www.arca.fiocruz.br/bitstream/icict/28878/2/PCR-RFLP%20assay.pdfb74efe965a98dad99302b9fbcd713ecbMD52TEXTPCR-RFLP assay.pdf.txtPCR-RFLP assay.pdf.txtExtracted texttext/plain31635https://www.arca.fiocruz.br/bitstream/icict/28878/3/PCR-RFLP%20assay.pdf.txt4f27bdc39ee417aafa4d4200e0e82efdMD53icict/288782019-06-19 10:12:54.484oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-06-19T13:12:54Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv PCR-RFLP assay as an option for primary HPV test
title PCR-RFLP assay as an option for primary HPV test
spellingShingle PCR-RFLP assay as an option for primary HPV test
Golfetto, Lisléia
cancer cervical
HPV
Triagem
PCR-RFLP
Microarranjo PapilloCheck®
Cervical cancer
HPV
Screening
PCR-RFLP
PapilloCheck® microarray
title_short PCR-RFLP assay as an option for primary HPV test
title_full PCR-RFLP assay as an option for primary HPV test
title_fullStr PCR-RFLP assay as an option for primary HPV test
title_full_unstemmed PCR-RFLP assay as an option for primary HPV test
title_sort PCR-RFLP assay as an option for primary HPV test
author Golfetto, Lisléia
author_facet Golfetto, Lisléia
Alves, Eduardo Venâncio
Martins, Toni Ricardo
Sincero, Thais Cristine Marques
Castro, J.B.S.
Dannebrock, Christian
Oliveira, Jaquelline Germano de
Levi, Jose Eduardo
Onofre, Alexandre Sherlley Casimiro
Bazzo, Maria Luiza
author_role author
author2 Alves, Eduardo Venâncio
Martins, Toni Ricardo
Sincero, Thais Cristine Marques
Castro, J.B.S.
Dannebrock, Christian
Oliveira, Jaquelline Germano de
Levi, Jose Eduardo
Onofre, Alexandre Sherlley Casimiro
Bazzo, Maria Luiza
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Golfetto, Lisléia
Alves, Eduardo Venâncio
Martins, Toni Ricardo
Sincero, Thais Cristine Marques
Castro, J.B.S.
Dannebrock, Christian
Oliveira, Jaquelline Germano de
Levi, Jose Eduardo
Onofre, Alexandre Sherlley Casimiro
Bazzo, Maria Luiza
dc.subject.other.pt_BR.fl_str_mv cancer cervical
HPV
Triagem
PCR-RFLP
Microarranjo PapilloCheck®
topic cancer cervical
HPV
Triagem
PCR-RFLP
Microarranjo PapilloCheck®
Cervical cancer
HPV
Screening
PCR-RFLP
PapilloCheck® microarray
dc.subject.en.pt_BR.fl_str_mv Cervical cancer
HPV
Screening
PCR-RFLP
PapilloCheck® microarray
description Universidade Federal de Santa Catarina. Laboratório de Biologia Molecular, Microbiologia e Sorologia. Florianópolis, SC, Brasil
publishDate 2018
dc.date.accessioned.fl_str_mv 2018-09-19T11:56:47Z
dc.date.available.fl_str_mv 2018-09-19T11:56:47Z
dc.date.issued.fl_str_mv 2018
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv GOLFETTO, Lisléia et al. PCR-RFLP assay as an option for primary HPV test. Braz J Med Biol Res, v. 51, n. 5, e7098, 2018.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/28878
dc.identifier.issn.pt_BR.fl_str_mv 0100-879X
dc.identifier.doi.none.fl_str_mv 10.1590/1414-431x20177098
identifier_str_mv GOLFETTO, Lisléia et al. PCR-RFLP assay as an option for primary HPV test. Braz J Med Biol Res, v. 51, n. 5, e7098, 2018.
0100-879X
10.1590/1414-431x20177098
url https://www.arca.fiocruz.br/handle/icict/28878
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/28878/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/28878/2/PCR-RFLP%20assay.pdf
https://www.arca.fiocruz.br/bitstream/icict/28878/3/PCR-RFLP%20assay.pdf.txt
bitstream.checksum.fl_str_mv 9193a7c197bc67acd023525e72a03240
b74efe965a98dad99302b9fbcd713ecb
4f27bdc39ee417aafa4d4200e0e82efd
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009164222332928